BIM
SUPN icon

BlackRock Investment Management’s Supernus Pharmaceuticals SUPN Stock Holding History

BlackRock Investment Management’s Portfolio SUPN Stock Details SUPN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		$6.11M Buy
242,062
+43,559
+22% +$973K 0.01% 1456
2016
Q3 		$4.91M Buy
198,503
+9,023
+5% +$204K 0.01% 1493
2016
Q2 		$3.86M Buy
189,480
+50,190
+36% +$890K ﹤0.01% 1618
2016
Q1 		$2.12M Sell
139,290
-9,648
-6% -$126K ﹤0.01% 1957
2015
Q4 		$2M Buy
148,938
+12,670
+9% +$196K ﹤0.01% 2084
2015
Q3 		$1.91M Sell
136,268
-971
-0.7% -$18.1K ﹤0.01% 2104
2015
Q2 		$2.33M Buy
137,239
+51,769
+61% +$737K ﹤0.01% 2108
2015
Q1 		$1.03M Buy
85,470
+539
+0.6% +$5.09K ﹤0.01% 2500
2014
Q4 		$705K Sell
84,931
-713
-0.8% -$5.99K ﹤0.01% 2791
2014
Q3 		$744K Buy
85,644
+1,368
+2% +$12.4K ﹤0.01% 2714
2014
Q2 		$923K Buy
84,276
+29,831
+55% +$266K ﹤0.01% 2665
2014
Q1 		$487K Buy
54,445
+10,420
+24% +$96K ﹤0.01% 2965
2013
Q4 		$332K Buy
44,025
+1,694
+4% +$11.8K ﹤0.01% 3130
2013
Q3 		$310K Buy
42,331
+3,022
+8% +$20.3K ﹤0.01% 3103
2013
Q2 		$253K Buy
+39,309
New +$232K ﹤0.01% 3118

Other funds holding SUPN

BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
RIM
Ranger Investment Management Dallas, Texas $1.38B AUM 24.55% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
GT
Glenmede Trust Philadelphia, Pennsylvania $20.4B AUM
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

BlackRock Investment Management's SUPN Position: Q4 2016 in Review

BlackRock Investment Management increased its Supernus Pharmaceuticals (SUPN) stake by 22% in Q4 2016, buying an estimated $973K and bringing the position to 242,062 shares worth $6.11M. The position accounts for 0.01% of the portfolio, ranked #1456.

BlackRock Investment Management first reported a position in SUPN in Q2 2013 and has held it in 15 quarters since. 233 funds tracked by Wall St. Rank hold SUPN as of Q4 2016.

  • BlackRock Investment Management held 242,062 shares of Supernus Pharmaceuticals worth $6.11M as of Q4 2016.
  • BlackRock Investment Management bought 43,559 Supernus Pharmaceuticals shares in Q4 2016, an estimated $973K.
  • Supernus Pharmaceuticals made up 0.01% of BlackRock Investment Management's portfolio in Q4 2016, its #1456 holding.
  • BlackRock Investment Management first reported a position in Supernus Pharmaceuticals in Q2 2013 and has held it in 15 quarters since.
  • 233 funds tracked by Wall St. Rank held Supernus Pharmaceuticals as of Q4 2016.

Based on BlackRock Investment Management's 13F filing for Q4 2016, filed 10 Feb 2017.